{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T07:07:05Z","timestamp":1776323225522,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,23]],"date-time":"2018-01-23T00:00:00Z","timestamp":1516665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,23]],"date-time":"2018-01-23T00:00:00Z","timestamp":1516665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Homeless persons have elevated risk of tuberculosis (TB) and are under-served by conventional health services. Approaches to active case-finding (ACF) and treatment tailored to their needs are required. A transmission-dynamic model was developed to assess the effectiveness and efficiency of screening with mobile Chest X-ray, GeneXpert, or both. Effectiveness of ACF depends upon the prevalence of infection in the population (which determines screening \u2018yield\u2019), patient willingness to wait for GeneXpert results, and treatment adherence. ACF is efficient when TB prevalence exceeds 78\/100,000 and 46% of drug sensitive TB cases and 33% of multi-drug resistant TB cases complete treatment. This threshold increases to 92\/100,000 if additional post-ACF enhanced case management (ECM) increases treatment completion to 85%. Generally, the most efficient option is one-step screening of all patients with GeneXpert, but if too many patients (&gt;27% without ECM, &gt;19% with ECM) are unwilling to wait the 90\u2009minutes required then two-step screening using chest X-ray (which is rapid) followed by GeneXpert for confirmation of TB is the most efficient option. Targeted ACF and support services benefit health through early successful treatment and averting TB transmission and disease. The optimal strategy is setting-specific, requiring careful consideration of patients\u2019 needs regarding testing and treatment.<\/jats:p>","DOI":"10.1038\/s41598-018-19757-5","type":"journal-article","created":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T12:16:04Z","timestamp":1516191364000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Comparing different technologies for active TB case-finding among the homeless: a transmission-dynamic modelling study"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7515-8548","authenticated-orcid":false,"given":"Tendai","family":"Mugwagwa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4022-3447","authenticated-orcid":false,"given":"Helen R.","family":"Stagg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0370-1430","authenticated-orcid":false,"given":"Ibrahim","family":"Abubakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6644-3512","authenticated-orcid":false,"given":"Peter J.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,23]]},"reference":[{"key":"19757_CR1","unstructured":"Davidson, J. A. et al. Tuberculosis in England: annual report. https:\/\/www.gov.uk\/government\/publications\/tuberculosis-in-england-annual-report. (Accessed: 26th January 2017). (2016)."},{"key":"19757_CR2","unstructured":"Abubakar, I. et al. Collaborative tuberculosis strategy for England. https:\/\/www.gov.uk\/government\/publications\/collaborative-tuberculosis-strategy-for-england. (Accessed: 29th January 2015) (2015)."},{"key":"19757_CR3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3389\/fmicb.2016.00394","volume":"7","author":"PJ White","year":"2016","unstructured":"White, P. J. & Abubakar, I. Improving Control of Tuberculosis in Low-Burden Countries: Insights from Mathematical Modeling. Front. Microbiol. 7, 394, https:\/\/doi.org\/10.3389\/fmicb.2016.00394 (2016).","journal-title":"Front. Microbiol."},{"key":"19757_CR4","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.5588\/ijtld.14.0105","volume":"18","author":"K Paquette","year":"2014","unstructured":"Paquette, K. et al. Chest radiography for active tuberculosis case finding in the homeless: a systematic review and meta-analysis. Int. J. Tuberc. Lung Dis. 18, 1231\u20136, https:\/\/doi.org\/10.5588\/ijtld.14.0105 (2014).","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"19757_CR5","doi-asserted-by":"publisher","first-page":"649","DOI":"10.5588\/ijtld.11.0241","volume":"16","author":"C Bernard","year":"2012","unstructured":"Bernard, C. et al. Impact of a 14-year screening programme on tuberculosis transmission among the homeless in Paris. Int. J. Tuberc. Lung Dis. 16, 649\u201355, https:\/\/doi.org\/10.5588\/ijtld.11.0241 (2012).","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"19757_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1164\/rccm.200612-1877OC","volume":"176","author":"G de Vries","year":"2007","unstructured":"de Vries, G., van Hest, R. A. H. & Richardus, J. H. Impact of mobile radiographic screening on tuberculosis among drug users and homeless persons. Am. J. Respir. Crit. Care Med. 176, 201\u2013207, https:\/\/doi.org\/10.1164\/rccm.200612-1877OC (2007).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"19757_CR7","doi-asserted-by":"publisher","first-page":"CD009593","DOI":"10.1002\/14651858.CD009593.pub3","volume":"1","author":"KR Steingart","year":"2014","unstructured":"Steingart, K. R. et al. Xpert\u00ae MTB\/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst. Rev. 1, CD009593, https:\/\/doi.org\/10.1002\/14651858.CD009593.pub3 (2014).","journal-title":"Cochrane Database Syst. Rev."},{"key":"19757_CR8","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S0140-6736(13)62073-5","volume":"383","author":"G Theron","year":"2014","unstructured":"Theron, G. et al. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB\/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial. Lancet 383, 424\u2013435, https:\/\/doi.org\/10.1016\/S0140-6736(13)62073-5 (2014).","journal-title":"Lancet"},{"key":"19757_CR9","doi-asserted-by":"publisher","first-page":"e1001120","DOI":"10.1371\/journal.pmed.1001120","volume":"8","author":"A Vassall","year":"2011","unstructured":"Vassall, A. et al. Rapid diagnosis of tuberculosis with the Xpert MTB\/RIF assay in high burden countries: a cost-effectiveness analysis. PLoS Med. 8, e1001120, https:\/\/doi.org\/10.1371\/journal.pmed.1001120 (2011).","journal-title":"PLoS Med."},{"key":"19757_CR10","doi-asserted-by":"publisher","first-page":"e70485","DOI":"10.1371\/journal.pone.0070485","volume":"8","author":"DW Dowdy","year":"2013","unstructured":"Dowdy, D. W. et al. Population-Level Impact of Same-Day Microscopy and Xpert MTB\/RIF for Tuberculosis Diagnosis in Africa. PLoS One 8, e70485, https:\/\/doi.org\/10.1371\/journal.pone.0070485 (2013).","journal-title":"PLoS One"},{"key":"19757_CR11","doi-asserted-by":"publisher","first-page":"d5376","DOI":"10.1136\/bmj.d5376","volume":"343","author":"M Jit","year":"2011","unstructured":"Jit, M. et al. Dedicated outreach service for hard to reach patients with tuberculosis in London: observational study and economic evaluation. Br. Med. J. 343, d5376, https:\/\/doi.org\/10.1136\/bmj.d5376 (2011).","journal-title":"Br. Med. J."},{"key":"19757_CR12","unstructured":"Combined Homelessness and Information Network. http:\/\/data.london.gov.uk\/dataset\/chain-reports. (Accessed: 7th March 2016) (2016)."},{"key":"19757_CR13","doi-asserted-by":"publisher","unstructured":"Drobniewski, F. et al. Systematic review, meta-analysis and economic modelling of molecular diagnostic tests for antibiotic resistance in tuberculosis. Health Technol. Assess. 19, 1\u2013188, vii\u2013viii, https:\/\/doi.org\/10.3310\/hta19340 (2015).","DOI":"10.3310\/hta19340"},{"key":"19757_CR14","unstructured":"National Institute for Health and Care Excellence. Methods for Development of NICE Public Health Guidelines. http:\/\/www.nicedsu.org.uk\/NICE-Methods-Guide-updates(1985333).htm. (Accessed: 28th August 2014) (2013)."},{"key":"19757_CR15","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1136\/postgradmedj-2015-133278","volume":"92","author":"P Cudahy","year":"2016","unstructured":"Cudahy, P. & Shenoi, S. V. Diagnostics for pulmonary tuberculosis. Postgrad. Med. J. 92, 187\u201393, https:\/\/doi.org\/10.1136\/postgradmedj-2015-133278 (2016).","journal-title":"Postgrad. Med. J."},{"key":"19757_CR16","doi-asserted-by":"publisher","first-page":"e273","DOI":"10.1371\/journal.pmed.0030273","volume":"3","author":"JA Salomon","year":"2006","unstructured":"Salomon, J. A. et al. Prospects for advancing tuberculosis control efforts through novel therapies. PLoS Med. 3, e273, https:\/\/doi.org\/10.1371\/journal.pmed.0030273 (2006).","journal-title":"PLoS Med."},{"key":"19757_CR17","doi-asserted-by":"publisher","first-page":"13980","DOI":"10.1073\/pnas.0901720106","volume":"106","author":"LJ Abu-Raddad","year":"2009","unstructured":"Abu-Raddad, L. J. et al. Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proc Natl Acad Sci USA 106, 13980\u201313985, https:\/\/doi.org\/10.1073\/pnas.0901720106 (2009).","journal-title":"Proc Natl Acad Sci USA"},{"key":"19757_CR18","unstructured":"Department for Communities and Local Government. Annual report on rough sleeping. http:\/\/webarchive.nationalarchives.gov.uk\/20120919132719\/http:\/www.communities.gov.uk\/documents\/housing\/pdf\/156723.pdf. (Accessed: 23rd May 2017) (1998)."},{"key":"19757_CR19","unstructured":"National Tuberculosis Institute. Tuberculosis in a rural population of South India: a five-year epidemiological study. Bull. World Health Organ. 51, 473\u201388 (1974)."},{"key":"19757_CR20","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1086\/517536","volume":"44","author":"HS Cox","year":"2007","unstructured":"Cox, H. S. et al. Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance. Clin. Infect. Dis. 44, 1421\u20137, https:\/\/doi.org\/10.1086\/517536 (2007).","journal-title":"Clin. Infect. Dis."},{"key":"19757_CR21","unstructured":"Abubakar, I. et al. Evaluation of the find and treat service for the control of tuberculosis amongst hard to reach groups. http:\/\/www.nice.org.uk\/guidance\/ph37\/documents\/economic-analysis-of-identifying-and-managing-tuberculosis-in-hard-to-reach-groups-homeless-and-prison-populations-2. (Accessed: 21st January 2015) (2011)."},{"key":"19757_CR22","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa0907847","volume":"363","author":"CC Boehme","year":"2010","unstructured":"Boehme, C. C. et al. Rapid Molecular Detection of Tuberculosis and Rifampin Resistance. N. Engl. J. Med. 363, 1005\u20131015, https:\/\/doi.org\/10.1056\/NEJMoa0907847 (2010).","journal-title":"N. Engl. J. Med."},{"key":"19757_CR23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1136\/thx.2007.083816","volume":"63","author":"M Taegtmeyer","year":"2008","unstructured":"Taegtmeyer, M. et al. The clinical impact of nucleic acid amplification tests on the diagnosis and management of tuberculosis in a British hospital. Thorax 63, 317\u201321, https:\/\/doi.org\/10.1136\/thx.2007.083816 (2008).","journal-title":"Thorax"},{"key":"19757_CR24","unstructured":"NHS. NHS England guide to the Enhanced Tariff Option for 2015\/16. https:\/\/www.england.nhs.uk\/resources\/pay-syst\/tariff-guide\/ (Accessed: 10th March 2016) (2015)."},{"key":"19757_CR25","unstructured":"Curtis, L. & Burns, A. Unit Costs of Health and Social Care. www.pssru.ac.uk\/pub\/uc\/uc2016\/full.pdf. (Accessed: 16th November 2017) (2016)."},{"key":"19757_CR26","unstructured":"FIND. Digital radiology solutions for TB diagnostics in low- to middle-income countries. http:\/\/www.finddiagnostics.org\/resource-centre\/find_reports\/digital-radiology-solutions-for-TB-dx.html. (Accessed: 14th March 2016) (2015)."},{"key":"19757_CR27","unstructured":"NICE. Xpert Carba-R to identify people carrying carbapenemase-producing organisms. https:\/\/www.nice.org.uk\/advice\/mib52\/chapter\/Technology-overview#costs-and-use-of-the-technology. (Accessed: 13th November 2017)."},{"key":"19757_CR28","unstructured":"Stop TB Partnership. TB REACH Xpert Budget Estimation Tool. http:\/\/www.stoptb.org\/global\/awards\/tbreach\/bet.asp. (Accessed: 13th November 2017)."},{"key":"19757_CR29","doi-asserted-by":"crossref","unstructured":"Kind, P., Dolan, P., Gudex, C. & Williams, A. Variations in population health status: results from a United Kingdom national questionnaire survey. 316, 736\u2013741 (1998).","DOI":"10.1136\/bmj.316.7133.736"},{"key":"19757_CR30","first-page":"296","volume":"14","author":"ME Kruijshaar","year":"2010","unstructured":"Kruijshaar, M. E. et al. Health status of UK patients with active tuberculosis. Int. J. Tuberc. Lung Dis. Off. J. Int. Union Against Tuberc. Lung Dis. 14, 296\u2013302 (2010).","journal-title":"Int. J. Tuberc. Lung Dis. Off. J. Int. Union Against Tuberc. Lung Dis."},{"key":"19757_CR31","doi-asserted-by":"publisher","first-page":"e29775","DOI":"10.1371\/journal.pone.0029775","volume":"7","author":"W Kittikraisak","year":"2012","unstructured":"Kittikraisak, W. et al. Health related quality of life among patients with tuberculosis and HIV in Thailand. PLoS One 7, e29775, https:\/\/doi.org\/10.1371\/journal.pone.0029775 (2012).","journal-title":"PLoS One"},{"key":"19757_CR32","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/S0140-6736(98)03406-0","volume":"353","author":"MA Behr","year":"1999","unstructured":"Behr, M. A. et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 353, 444\u2013449 (1999).","journal-title":"Lancet"},{"key":"19757_CR33","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1183\/09031936.93.03040385","volume":"3","author":"DA Mitchison","year":"1990","unstructured":"Mitchison, D. A. Infectivity of patients with pulmonary tuberculosis during chemotherapy. Eur. Respir. J. 3, 385\u2013386 (1990).","journal-title":"Eur. Respir. J."},{"key":"19757_CR34","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1586\/17476348.3.1.67","volume":"3","author":"T Cohen","year":"2009","unstructured":"Cohen, T., Dye, C., Colijn, C., Williams, B. & Murray, M. Mathematical models of the epidemiology and control of drug-resistant TB. Expert Rev. Respir. Med. 3, 67\u201379, https:\/\/doi.org\/10.1586\/17476348.3.1.67 (2009).","journal-title":"Expert Rev. Respir. Med."},{"key":"19757_CR35","unstructured":"Health Protection Agency. TB Reference Laboratories. http:\/\/www.hpa.org.uk\/Topics\/InfectiousDiseases\/InfectionsAZ\/Tuberculosis\/LaboratoryInformation. (Accessed: 28th August 2014)."},{"key":"19757_CR36","doi-asserted-by":"publisher","first-page":"e188","DOI":"10.1371\/journal.pmed.0050188","volume":"5","author":"AR Escombe","year":"2008","unstructured":"Escombe, A. R. et al. The Infectiousness of Tuberculosis Patients Coinfected with HIV. PLoS Med 5, e188, https:\/\/doi.org\/10.1371\/journal.pmed.0050188 (2008).","journal-title":"PLoS Med"},{"key":"19757_CR37","unstructured":"WHO. Global tuberculosis report. http:\/\/www.who.int\/tb\/publications\/global_report\/en\/. (Accessed: 2nd September 2014) (2014)."},{"key":"19757_CR38","doi-asserted-by":"publisher","unstructured":"Hislop, J. et al. Systematic review of the clinical effectiveness and cost-effectiveness of rapid point-of-care tests for the detection of genital chlamydia infection in women and men. Heal. Technol. Assess. 14, 1\u201397, iii\u2013iv, https:\/\/doi.org\/10.3310\/hta14290 (2010).","DOI":"10.3310\/hta14290"},{"key":"19757_CR39","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1136\/thx.2006.065409","volume":"62","author":"A Story","year":"2007","unstructured":"Story, A., Murad, S., Roberts, W., Verheyen, M. & Hayward, A. C. Tuberculosis in London: the importance of homelessness, problem drug use and prison. Thorax 62, 667\u2013671, https:\/\/doi.org\/10.1136\/thx.2006.065409 (2007).","journal-title":"Thorax"},{"key":"19757_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-532","volume":"14","author":"AH Van\u2019t Hoog","year":"2014","unstructured":"Van\u2019t Hoog, A. H., Onozaki, I. & Lonnroth, K. Choosing algorithms for TB screening: a modelling study to compare yield, predictive value and diagnostic burden. BMC Infect. Dis. 14, 532, https:\/\/doi.org\/10.1186\/1471-2334-14-532 (2014).","journal-title":"BMC Infect. Dis."},{"key":"19757_CR41","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1177\/0956462415591414","volume":"27","author":"LM Atkinson","year":"2016","unstructured":"Atkinson, L. M., Vijeratnam, D., Mani, R. & Patel, R. \u2018The waiting game\u2019: are current chlamydia and gonorrhoea near-patient\/point-of-care tests acceptable to service users and will they impact on treatment? Int. J. STD AIDS 27, 650\u2013655, https:\/\/doi.org\/10.1177\/0956462415591414 (2016).","journal-title":"Int. J. STD AIDS"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19757-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19757-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19757-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T01:22:21Z","timestamp":1671585741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19757-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,23]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["19757"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-19757-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,23]]},"assertion":[{"value":"29 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.R.S. and P.J.W. have received research funding from Otsuka SA for an audit of multidrug-resistant tuberculosis treatment in several eastern European countries. A study (ISRCTN04379941) on which H.R.S. is a co-applicant has received free drugs from Sanofi for a randomised controlled trial of the treatment of latent tuberculosis. H.R.S. has also previously received travel expenses from the World Health Organization to attend a meeting on latent tuberculosis.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1433"}}